2nd Quarter - Report

BIOCOM for BIOCOM

Period 2nd Quarter 2016 Filed Jul 20, 2016 Signed by Laure Fabrega

Official filing
Firm
BIOCOM
Client
BIOCOM
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Urged Congress to support GMO labeling legislation.

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

Asked for increased NIH funding.

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

Asked Congress to prioritize the use of telehealth and remote patient monitoring technologies. Hosted a Precision Medicine Briefing to educate regulators and legislators about precision medicine. Expressed support for Senate biomedical initiative. Hosted Congressional Briefing on Value of Biomedical Innovation. Hosted life science reception on Capitol Hill.

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Raised concerns regarding CMS' Part B Demo. Submitted comments to CMS expressing concerns regarding Prop B Demo. rule. Submitted comments to CMS regarding MACWA rule

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.